Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Stanford University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Stanford University
Collaborators:
University of Cincinnati
Baylor College of Medicine
Weill Medical College of Cornell University
University of Iowa
University of Texas
George Washington University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01129687
First received: March 10, 2010
Last updated: March 12, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.
| Condition | Intervention |
|---|---|
|
Neuroma, Acoustic |
Procedure: Microsurgery Procedure: Stereotactic radiation therapy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Multicenter Prospective Analysis of Treatment Outcome in Patients With Large Acoustic Neuromas |
Resource links provided by NLM:
MedlinePlus related topics:
Acoustic Neuroma
Genetic and Rare Diseases Information Center resources:
APUDoma
Acoustic Neuroma
Carcinoid Tumor
Nerve Sheath Neoplasm
Neuroepithelioma
Schwannoma
U.S. FDA Resources
Further study details as provided by Stanford University:
Primary Outcome Measures:
- Need for stereotactic radiation therapy should tumor remnant grow on annual MRI's [ Time Frame: 10 years ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Facial nerve function measured on House-Brackmann scale [ Time Frame: 10 y ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 100 |
| Study Start Date: | March 2005 |
| Estimated Study Completion Date: | March 2015 |
| Estimated Primary Completion Date: | March 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
ANSRS group
Patients qualifying for the study.
|
Procedure: Microsurgery
Patient would under to total, near-total, or subtotal resection of tumor
Procedure: Stereotactic radiation therapy
Patient who has sign of growth of tumor remnant would undergo this treatment
|
Detailed Description:
The current standard treatment of a large tumor of the balance nerve (acoustic neuroma or vestibular schwannoma) is surgical resection. Complete removal of such tumor is associated with significant risks of hearing loss and facial paralysis whereas incomplete removal of the tumor is associated with significant risks of regrowth. Stereotactic radiation is a well accepted therapy aiming at stopping the growth of smaller acoustic neuromas before their sizes become large enough to cause problems. The purpose of our study is to determine whether the combination of subtotal resection followed by stereotactic radiation of the remnant can control large acoustic neuromas without the significant risks associated with complete resection.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients with large acoustic neuromas measuring 2.5cm in longest dimension in the cerebellopontine angle.
Criteria
Inclusion Criteria:
- Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the cerebellopontine angle are eligible for this trial.
- Patients that are deemed good surgical candidates based on age, general health, genetic predispositions, and hearing in contralateral side would be included as the subjects of this trial.
- Although we would include patients with neurofibromatosis II in this trial, considering their genetic predisposition for recurrence, we would analyze their outcome as a separate group.
Exclusion Criteria:
- Patients who have received any form of treatment of their acoustic neuromas prior to enrollment in the study including surgery or radiation therapy.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01129687
Please refer to this study by its ClinicalTrials.gov identifier: NCT01129687
Contacts
| Contact: ashkan monfared, MD | (202)741-3250 | monfared@gmail.com |
Locations
| United States, California | |
| Stanford University School of Medicine | Recruiting |
| Stanford, California, United States, 94305 | |
| Contact: ashkan monfared, MD 202-741-3250 monfared@gmail.com | |
| Principal Investigator: Dr Robert Jackler | |
| Study Director: Ashkan Monfared | |
| United States, District of Columbia | |
| George Washington University | Recruiting |
| Washington, District of Columbia, United States, 20037 | |
| Contact: Ashkan Monfared, MD 202-741-3017 monfared@gmail.com | |
| Contact: Shelly Greene 202-741-3450 sgreene@mfa.gwu.edu | |
| Principal Investigator: Ashkan Monfared, MD | |
| United States, Iowa | |
| University of Iowa | Recruiting |
| Iowa City, Iowa, United States, 52242 | |
| Contact: Marlan Hansen, MD 319-353-7151 marlan-hansen@uiowa.edu | |
| Principal Investigator: Marlan Hansen, MD | |
| United States, New York | |
| Weill Cornell Medical College | Recruiting |
| New York, New York, United States | |
| Contact: Teresa Valderrama, MPH 646-962-5399 tev2002@med.cornell.edu | |
| Principal Investigator: Samuel Selesnick | |
| United States, Ohio | |
| University of Cincinnati | Recruiting |
| Cincinnati, Ohio, United States | |
| Contact: Carolyn Koenig, RN 513-558-3518 koenigch@UCMAIL.UC.EDU | |
| Principal Investigator: Phillip Theodosopoulos | |
| United States, Texas | |
| University of Texas Southwestern | Recruiting |
| Dallas, Texas, United States, 75390 | |
| Contact: Anna Bryan 214-648-2913 Anna.Bryan@utsouthwestern.edu | |
| Contact: Walter Kutz, MD 214-648-2432 Walter.Kutz@utsouthwestern.edu | |
| Principal Investigator: Walter Kutz, MD | |
| Baylor College of Medicine | Active, not recruiting |
| Houston, Texas, United States | |
Sponsors and Collaborators
Stanford University
University of Cincinnati
Baylor College of Medicine
Weill Medical College of Cornell University
University of Iowa
University of Texas
George Washington University
Investigators
| Study Director: | Ashkan Monfared | Stanford University |
More Information
No publications provided
| Responsible Party: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT01129687 History of Changes |
| Other Study ID Numbers: | SU-03052010-5142 |
| Study First Received: | March 10, 2010 |
| Last Updated: | March 12, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Neuroma Neuroma, Acoustic Cranial Nerve Diseases Cranial Nerve Neoplasms Ear Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Nerve Sheath Neoplasms |
Nervous System Diseases Nervous System Neoplasms Neurilemmoma Neuroectodermal Tumors Neuroendocrine Tumors Otorhinolaryngologic Diseases Otorhinolaryngologic Neoplasms Peripheral Nervous System Neoplasms Retrocochlear Diseases Vestibulocochlear Nerve Diseases |
ClinicalTrials.gov processed this record on March 03, 2015